Related references
Note: Only part of the references are listed.The Qualification of Docetaxel or Erlotinib for Second-Line Therapy Should Be Based on Clinical and Molecular Predictive Factors
Pawel Krawczyk et al.
CHEMOTHERAPY (2012)
Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer
K. Takezawa et al.
BRITISH JOURNAL OF CANCER (2011)
Low-Dose Weekly Docetaxel Is as Tolerable as Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer
Fu-Tsai Chung et al.
CHEMOTHERAPY (2011)
Significance of Thymidylate Synthase and Thyroid Transcription Factor 1 Expression in Patients with Nonsquamous Non-small Cell Lung Cancer Treated with Pemetrexed-Based Chemotherapy
Jong-Mu Sun et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed
Chung-Yu Chen et al.
LUNG CANCER (2011)
A Cost-Effectiveness Analysis of Docetaxel versus Pemetrexed in Second-Line Chemotherapy for Stage IIIb or IV Non-Small Cell Lung Cancer in China
Yong-feng Yu et al.
CHEMOTHERAPY (2010)
Comparison of Patient Outcomes According to Histology Among Pemetrexed-Treated Patients With Stage IIIB/IV Non-Small-Cell Lung Cancer in Two Phase II Trials
Ralph G. Zinner et al.
CLINICAL LUNG CANCER (2010)
The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action
M. Joerger et al.
CURRENT DRUG TARGETS (2010)
The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer
Myung Hee Chang et al.
LUNG CANCER (2010)
Efficacy and Toxicity of Pemetrexed as a Third-line Treatment for Non-small Cell Lung Cancer
Jong-Mu Sun et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2009)
Efficacy Differences of Pemetrexed by Histology in Pretreated Patients with Stage IIIB/IV Non-small Cell Lung Cancer Review of Results from an Open-Label Randomized Phase II Study
Kaoru Kubota et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
Tudor Ciuleanu et al.
LANCET (2009)
Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancer
Yuichiro Ohe et al.
CLINICAL CANCER RESEARCH (2008)
Relationship between response and survival in more than 50,000 patients with advanced non-small cell lung cancer treated with systemic chemotherapy in 143 phase III trials
Katsuyuki Hotta et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
Y. Ohe et al.
ANNALS OF ONCOLOGY (2007)
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase
Paolo Ceppi et al.
CANCER (2006)
Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung
H Hashimoto et al.
CANCER (2006)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Expression of thymidylate synthase is correlated with proliferative activity in non-small cell lung cancer (NSCLC)
T Nakagawa et al.
LUNG CANCER (2004)
A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer
E Massarelli et al.
LUNG CANCER (2003)
Prognostic value of thymidylate synthase expression in patients with p-stage I adenocarcinoma of the lung
T Nakagawa et al.
LUNG CANCER (2002)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
FA Shepherd et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
